Gastrointestinal, Endocrine, Nutrition & Blood Medicines
Estimated value
—
Awarded value
—
Suppliers
70
Lots
14
Published
25 Jul 2025
Description
This Framework Agreement is for the supply of Gastrointestinal, Endocrine, Nutrition & Blood Medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Scope
- Reference
- NP39825
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 14 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 14 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Desferoxamine Injections | £481k | cancelled |
| 2 | Dexamethasone Injections | £484k | cancelled |
| 3 | Macrogol Oral Powder & Solutions | £4.7m | cancelled |
| 4 | Mesalazine Oral/Rectal Preparations | £105k | cancelled |
| 5 | Magnesium Sulfate Injection | £182k | cancelled |